Bulk pharma - group a (asset mgmt) doxycycline 25MG/5ML oral suspension, powder, 60ML bottle, ondansetron HCL 8MG, 30 tablets, bottle
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50325C00012
- Awardee
-
Chartwell RX LLC UEI ER5UA9TYBGH4
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $16,078,390
Award facts
- Contract value 38% obligated
-
- $16,078,389.60 Current, with exercised options
- $42,791,498.40 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Congers, NY 10920, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the supply of various pharmaceutical products, including doxycycline oral suspension, ondansetron hydrochloride tablets, and other critical medications. The contract is a definitive, firm fixed-price contract with a ceiling value of $42,791,498.40 and an ultimate completion date of August 31, 2030. The contract is not set aside for any specific business type. Chartwell RX LLC is a prime contractor with significant experience in fulfilling pharmaceutical requirements for federal agencies, including the Defense Logistics Agency (DLA) Troop Support Medical and the Department of Veterans Affairs. The company's Indefinite Delivery Vehicle (IDV) contracts enable it to provide a broad spectrum of medications to military treatment facilities and government healthcare systems.
Quick answers
Who was awarded contract 75A50325C00012?
75A50325C00012 was awarded to Chartwell RX LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 1, 2025.
How much is contract 75A50325C00012 worth?
The government has obligated $16,078,390 on 75A50325C00012. Its potential value, with all options, is $42,791,498.
Was contract 75A50325C00012 competed?
The extent of competition for 75A50325C00012 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award